## Core Concept
Primary hepatocellular carcinoma (HCC) is a type of liver cancer with various tumor markers that aid in its diagnosis and monitoring. Tumor markers are substances produced by cancer cells or in response to cancer. For HCC, the most commonly used tumor markers are alpha-fetoprotein (AFP), lens culinaris agglutinin-reactive alpha-fetoprotein (AFP-L3), and protein induced by vitamin K absence/antagonist-II (PIVKA-II), also known as des-gamma-carboxy prothrombin (DCP).

## Why the Correct Answer is Right
The correct answer, **D. CA 19-9**, is not typically associated with primary hepatocellular carcinoma. CA 19-9 is more commonly used as a tumor marker for pancreatic cancer. While it can be elevated in various types of cancers and conditions, it is not specific or sensitive for HCC.

## Why Each Wrong Option is Incorrect
- **Option A: AFP (Alpha-fetoprotein)**: This is a well-established tumor marker for HCC. Elevated levels are often seen in patients with HCC, making it useful for diagnosis and monitoring.
- **Option B: AFP-L3**: This is a variant of AFP and has been shown to be more specific for HCC than total AFP levels. It is used in combination with AFP and PIVKA-II for the diagnosis of HCC.
- **Option C: PIVKA-II (DCP)**: This is another tumor marker that has been found to be elevated in HCC. It is often used in conjunction with AFP for diagnosing HCC.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that while AFP is a useful marker for HCC, it is not elevated in all cases, particularly in early-stage disease or in well-differentiated tumors. Therefore, a combination of tumor markers (AFP, AFP-L3, and PIVKA-II) and imaging techniques is recommended for the diagnosis of HCC. Remember, **AFP < 20 ng/mL does not rule out HCC**, especially in early stages. ## Correct Answer: D. CA 19-9